Align Technology (ALGN) to Release Earnings on Wednesday

Align Technology (NASDAQ:ALGN) is expected to be releasing its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $2.99 per share and revenue of $1.0318 billion for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 4:30 PM ET.

Align Technology Stock Performance

ALGN stock opened at $163.63 on Tuesday. Align Technology has a 52 week low of $122.00 and a 52 week high of $232.20. The company’s 50-day simple moving average is $161.41 and its 200 day simple moving average is $148.74. The company has a market capitalization of $11.74 billion, a PE ratio of 31.71, a price-to-earnings-growth ratio of 1.83 and a beta of 1.83.

Hedge Funds Weigh In On Align Technology

Hedge funds have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd boosted its position in shares of Align Technology by 1,773.3% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 281 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 266 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in Align Technology in the second quarter valued at approximately $36,000. MUFG Securities EMEA plc bought a new position in shares of Align Technology during the 2nd quarter worth approximately $38,000. Advisory Services Network LLC acquired a new stake in shares of Align Technology during the 3rd quarter worth approximately $100,000. Finally, EverSource Wealth Advisors LLC grew its position in shares of Align Technology by 55.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 531 shares of the medical equipment provider’s stock worth $101,000 after buying an additional 190 shares during the period. Institutional investors own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ALGN. UBS Group reduced their price target on Align Technology from $160.00 to $155.00 and set a “neutral” rating on the stock in a research report on Thursday, October 16th. Morgan Stanley upped their target price on Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a research report on Thursday, October 30th. Wall Street Zen upgraded shares of Align Technology from a “hold” rating to a “buy” rating in a research note on Saturday, January 3rd. Evercore ISI cut their price target on shares of Align Technology from $220.00 to $170.00 and set an “outperform” rating for the company in a report on Tuesday, November 25th. Finally, Barclays initiated coverage on Align Technology in a report on Monday, December 8th. They issued an “equal weight” rating and a $170.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $176.82.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.